ALA — Arovella Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$104.88m
- AU$93.13m
- AU$0.16m
Annual cashflow statement for Arovella Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | — | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 1.02 | 1.12 | 0.528 | 1.08 | 2.07 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.88 | -3.54 | -6.27 | -6.4 | -6.91 |
| Capital Expenditures | -0.388 | -0.515 | -0.566 | -0.003 | -0.129 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 0.098 | -0.05 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.388 | -0.515 | -0.566 | 0.095 | -0.179 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.064 | 9.8 | 6.19 | 5.41 | 14.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.34 | 5.74 | -0.646 | -0.896 | 7.54 |